当前位置: X-MOL 学术Immunity › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
Immunity ( IF 25.5 ) Pub Date : 2017-12-12 , DOI: 10.1016/j.immuni.2017.11.016
Matthew A Coelho 1 , Sophie de Carné Trécesson 1 , Sareena Rana 2 , Davide Zecchin 1 , Christopher Moore 1 , Miriam Molina-Arcas 1 , Philip East 3 , Bradley Spencer-Dene 4 , Emma Nye 4 , Karin Barnouin 5 , Ambrosius P Snijders 5 , Wi S Lai 6 , Perry J Blackshear 7 , Julian Downward 8
Affiliation  

The immunosuppressive protein PD-L1 is upregulated in many cancers and contributes to evasion of the host immune system. The relative importance of the tumor microenvironment and cancer cell-intrinsic signaling in the regulation of PD-L1 expression remains unclear. We report that oncogenic RAS signaling can upregulate tumor cell PD-L1 expression through a mechanism involving increases in PD-L1 mRNA stability via modulation of the AU-rich element-binding protein tristetraprolin (TTP). TTP negatively regulates PD-L1 expression through AU-rich elements in the 3′ UTR of PD-L1 mRNA. MEK signaling downstream of RAS leads to phosphorylation and inhibition of TTP by the kinase MK2. In human lung and colorectal tumors, RAS pathway activation is associated with elevated PD-L1 expression. In vivo, restoration of TTP expression enhances anti-tumor immunity dependent on degradation of PD-L1 mRNA. We demonstrate that RAS can drive cell-intrinsic PD-L1 expression, thus presenting therapeutic opportunities to reverse the innately immunoresistant phenotype of RAS mutant cancers.



中文翻译:


致癌 RAS 信号通过稳定 PD-L1 mRNA 促进肿瘤免疫抵抗



免疫抑制蛋白 PD-L1 在许多癌症中表达上调,有助于逃避宿主免疫系统。肿瘤微环境和癌细胞内在信号传导在 PD-L1 表达调节中的相对重要性仍不清楚。我们报告,致癌 RAS 信号传导可以通过一种机制上调肿瘤细胞 PD-L1 表达,该机制涉及通过调节富含 AU 元件的结合蛋白 tristetraprolin (TTP) 来增加 PD-L1 mRNA 稳定性。 TTP 通过 PD-L1 mRNA 3' UTR 中富含 AU 的元件负向调节 PD-L1 表达。 RAS 下游的 MEK 信号传导导致激酶 MK2 磷酸化并抑制 TTP。在人类肺癌和结直肠肿瘤中,RAS 通路激活与 PD-L1 表达升高相关。在体内,TTP 表达的恢复可增强依赖于 PD-L1 mRNA 降解的抗肿瘤免疫。我们证明 RAS 可以驱动细胞内在的 PD-L1 表达,从而为逆转RAS突变癌症的先天免疫抵抗表型提供了治疗机会。

更新日期:2017-12-12
down
wechat
bug